Form 4 for AGIO AGIOS PHARMACEUTICALS, INC.
Accepted 2025-09-09 00:00:00 ET · period of report 2025-09-05 · accession 0001439222-25-000102 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-09 | 2025-09-05 | AGIO | Washburn Theodore James Jr. | Principal Accounting Off | S - Sale | $36.87 | -8,546 | 868 | -91% | -$315.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock | 2025-09-05 | S | D | 8,546 | $36.87 | 868 | D | — | — |